Related Experiment Videos
Preferentially expressed genes in stomach adenocarcinoma cells
T Shiosaka1, Y Tanaka, Y Kobayashi
1First Department of Internal Medicine, School of Medicine, Ehime University, Japan.
Abstract:
cDNA clones complementary to mRNA of neoplastic cells of human stomach tissue were used to examine quantitative changes in the mRNA levels of specific genes in neoplastic cells. Poly(A)+ RNA from poorly differentiated adenocarcinoma cells of a female patient with stomach cancer was used for construction of a complementary DNA (cDNA) library. Screening of the 18,000 colonies utilizing 32P-cDNAs derived from normal human tissue and stomach carcinoma tissue samples was used to select clones likely to represent sequences preferentially expressed in stomach carcinoma cells. Twenty-six recombinants were initially selected and further analysis of these clones indicated that eight (4-3D, 9-2D, 9-4G, 29-1G, 29-6F, 37-1B, 115-5A and 52-5F) contain sequences preferentially expressed in stomach carcinoma cells. We have identified the 9-4G, 29-1A, and 29-6F genes which are differentially expressed in human neoplasia.
Insights
Researchers identified specific genes that are more active in stomach cancer cells. This discovery aids in understanding stomach cancer development and may lead to new diagnostic tools for human neoplasia.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Stomach cancer involves complex genetic alterations.
- Understanding gene expression changes in neoplastic cells is crucial for diagnosis and treatment.
Purpose of the Study:
- To identify genes with altered expression levels in human stomach adenocarcinoma.
- To find molecular markers for stomach cancer detection.
Main Methods:
- Construction of a complementary DNA (cDNA) library from poorly differentiated adenocarcinoma cells.
- Screening of 18,000 cDNA clones using probes from normal and cancerous stomach tissue.
- Selection and analysis of recombinant clones showing preferential expression in cancer cells.
Main Results:
- Eight cDNA clones (4-3D, 9-2D, 9-4G, 29-1G, 29-6F, 37-1B, 115-5A, 52-5F) were identified as preferentially expressed in stomach carcinoma.
- Specific genes including 9-4G, 29-1A, and 29-6F were found to be differentially expressed in human neoplasia.
- Quantitative changes in mRNA levels of specific genes in neoplastic cells were examined.
Conclusions:
- The study successfully identified genes with altered expression patterns in stomach cancer.
- These differentially expressed genes represent potential biomarkers for human stomach neoplasia.
- Further research can explore the functional roles of these genes in cancer progression.